The latest report on ‘global biobanking market’ offers historical data, qualitative insights, and verifiable projections for the industry growth, with respect to the current and past industry trends.
Description: The latest report on ‘global biobanking market’ offers historical data, qualitative insights, and verifiable projections for the industry growth, with respect to the current and past industry trends. Further, it highlights the key drivers, opportunities, and challenges that will impact the market dynamics during 2020-2025.
According to trusted sources, global biobanking market was valued USD 2.08 billion in 2019 and is anticipated to grow with a CAGR of 23.7% over 2020-2027. Rising prevalence of chronic diseases and increasing investments from private and government organizations are the major factors fueling the industry growth.
The research literature hosts in-depth segmentation studies, including specimen type, biobank type, application, ownership and regional outlook. Moreover, it offers holistic view of competitive dynamics, showcasing a detailed account of the leading organizations, along with their product portfolio and industry share. Further, it sheds light on the global health crisis of Covid-19 pandemic, with an aim to assist businesses and other stakeholders in effectively managing the uncertainties and building contingency plans that ensure profitability in the coming years.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3110286/
Further, growing demand for cord blood as it contains stem cells, which are utilized for treating diseases various disorders, is propelling the market growth. However, ethical and regulatory concerns are negatively impacting global biobanking industry dynamics.
For the uninitiated, biobanking is a method of accumulating and storing biological resources that can later be used for ecosystem studies, diagnostics, and analysis.
Impact of COVID-19 pandemic
Spread of COVID-19 pandemic has raised the importance of biobanks worldwide. The rapid establishment of COVID-19 biobanks has facilitated prospective selection of research biospecimens and related clinical and patient data that enable high-quality research, thereby enhancing the overall biobanking industry outlook.
Citing an instance, in February 2020, the NHRI Biobank, Minister of Health and Welfare was assigned to create a COVID-19 biobank to collect blood samples of infected patients for Taiwanese researchers and industry. Likewise, several initiatives have been undertaken to further R&D of vaccines are ultimately accelerating the overall industry expansion.
Market segmentation overview
In terms of specimen type, global biobanking market is segmented into blood products, nucleic acid, cell lines, solid tissue, and others. Based on ownership, the industry is fragmented into university, national/regional agencies, private organization, and non-profit organization. With respect to biobank type, the market is classified into disease-oriented biobanks and population-based biobanks. Speaking of application, the market is divided into research and therapeutic.
To access a sample pages of this report titled “Global Biobanking Market Size study, By Specimen Type (Blood Products, Solid Tissue, Nucleic Acid, and Cell Lines, Others), Type of Biobank (Population-based Biobanks and Disease-oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private Organization), and Application (Therapeutic and Research), and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-biobanking-market-size-research
Regional landscape
From a regional frame of reference, Europe, Asia Pacific, North America, and Latin America are the key contributors to worldwide biobanking market remuneration. Industry experts claim that Asia Pacific market is projected to record significant growth during the study period, mainly due to increasing population and presence of large geriatric populace. In addition, rising healthcare expenditure and the developing guidelines are likely to fuel demand for biobanking in the region.
Global Biobanking Market Specimen Type (Revenue, USD Billion, 2017-2027)
- Blood Products
- Solid Tissue
- Cell Lines
- Nucleic Acid
- Others
Global Biobanking Market Biobank Type (Revenue, USD Billion, 2017-2027)
- Population-based Biobanks
- Disease-oriented Biobanks
Global Biobanking Market Application Spectrum (Revenue, USD Billion, 2017-2027)
- Therapeutic
- Research
Global Biobanking Market Ownership Sub-Segments (Revenue, USD Billion, 2017-2027)
- National/Regional Agencies
- Non-profit Organization
- University
- Private Organization
Global Biobanking Market Regional Fragmentation (Revenue, USD Billion, 2017-2027)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of the World
Global Biobanking Market Company Profiles (Revenue, USD Billion, 2017-2027)
- Panasonic Healthcare Holdings Co., Ltd.
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- VWR International
- Merck Group
- Brooks Automation, Inc.
- Tecan Trading AG
- Hamilton Company
- Chart Industries, Inc.
- Qiagen N.V.
- Greiner Holding AG
- Promega Corporation
Related Report:
U.S. Ambulatory Surgical Centers Market Size, Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
U.S. ambulatory surgical centers market is anticipated to witness unprecedented growth throughout the forecast timeframe. This can be primarily attributed to the growing burden of various chronic health conditions among the U.S. adult and geriatric population. Ambulatory surgical centers continue to gain prominence as cost-effective and faster options for surgeries as compared to hospitals and other medical establishments. U.S. ambulatory surgical centers industry can be classified into dental, endoscopy, plastic surgery, obstetrics/gynecology, neurology, cardiovascular, orthopedic, and others. Plastic surgery segment is estimated to be worth more than US$3 billion by 2026 owing to a substantial rise in the number of aesthetic surgical procedures in the U.S. over the past few years.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us:
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com